Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Placebo Controlled, Randomized, Double-Blinded Study: Coenzyme Q10 Nanodispersion Versus Placebo as Symptomatic Treatment in Parkinson's Disease

NCT00180037 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.

NCT NCT00180037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00180037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Placebo Controlled, Randomized, Double-Blinded Study: Coenzyme Q10 Nanodispersion Versus Placebo as Symptomatic Treatment in Parkinson's Disease
Lead sponsor
Technische Universität Dresden
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2003
Completion date
June 30, 2005
Enrollment
132
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease